🙂 New evidence of Trump – Putin collusion! Trump and Putin both encouraged the use of hydroxychloroquine for COVID-19 treatment and prevention, despite the lack of evidence of its efficacy (not counting in-vitro research, clinical success in France, South Korea, China, and some 3-4 randomized controlled trials). Russia and the “Trump country” states report less than 100 COVID-19 deaths per million population. Russia has embraced hydroxychloroquine-based treatment for COVID-19. Continue reading Trump – Putin Collusion in COVID19
Stop Facebook, Twitter, and Google
No, a red triangle with a black outline is not a nazi symbol. Far left outfits Color of Change and/or Bend the Arc have shown a red triangle, attached to prisoners’ uniform, and a document in German. This is a smear campaign. The attempted demonetizing of The Federalist was the first shot in it. Continue reading Stop Facebook, Twitter, and Google
HCQ is Very Effective for COVID19, Doctors Say
On May 22-24, Sermo surveyed more than 4,000 physicians globally, 555 of whom treated COVID-19 patients. The results:
- Hydroxychloroquine-based treatment remain the first choice of doctors for outpatient treatment globally, with a few exceptions such as the US, UK, Canada.
- No treatment is the first choice of doctors in the US and UK; HCQ-based treatments are the second choice
- 35% of doctors using it said that Hydroxychloroquine is Extremely Effective or Very Effective in treating COVID-19 (excluding ‘no opinion’ answer)
Only 14% of US doctors treated outpatients with HCQ, compared with 30% abroad. “AZM or similar” was used by only 26% of US doctors compared with 49% abroad. It was even worse in the UK and Canada. Continue reading HCQ is Very Effective for COVID19, Doctors Say
Boulware et al. Affirms HCQ Efficacy, but Misinterpreted
July 18 update. This study (NCT04308668, 03/17 – 05/20) has a second part, which was mis-reported on July 16 as Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19 in the Annals of Internal Medicine. At the closer look, the study started on March 11 as a bona fide clinical trial, which devolved into a scientific fraud on or after March 24. Read about it above: anti-HCQ Scientific Fraud, BS-2.
The first author, Dr. David Boulware, falsely denied that he was hired by Revive Therapeutics Ltd., a psychedelic mushrooms peddler, as Scientific Advisor to promote its “orphan drug” Bucillamine (unrelated to psychedelic mushrooms), as a competitor to HCQ for COVID-19 .
Continue reading Boulware et al. Affirms HCQ Efficacy, but Misinterpreted
Preparations to Pandemic Flu, 2006
Inglesby et al., Disease Mitigation Measures in the Control of Pandemic Influenza; Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science; 2006
It has been recognized that most actions taken to counter pandemic influenza will have to be undertaken by local governments, given that the epidemic response capacity of the federal government is limited. Continue reading Preparations to Pandemic Flu, 2006
Re HCQ Shortages
A new article in JAMA Network (Vaduganathan et al.) describes a peak in hydroxycholoroquine dispensing by pharmacies in the week of March 15-21, although misinterprets its cause. But its statistics confirms conclusions of my article Distributed Denial of HCQ to COVID-19 Victims, published in WUWT on May 11. That was panic buying by chronic lupus and/or rheumatoid arthritis patients, triggered by the news media and amplified by Google and so-called social media. On March 20, multiple outlets announced that HCQ buying by COVID-19 patients was causing shortages for its “legitimate users”. There were no shortages at that time. But multiple repetitions of that lie caused lupus and RA patients to buy as much HCQ as they could – and many had unfulfilled prescriptions for 90 days.That led to actual shortages in a few days. Continue reading Re HCQ Shortages
Surgisphere’s COVID-19 Tools are Deadly Fraud
June 12: Surgisphere’s website is suspended by the hosting provider.
Continue reading Surgisphere’s COVID-19 Tools are Deadly Fraud
Anti-HCQ Paper in The Lancet Uses Fake Data
Good news: Early Outpatient Treatment of Symptomatic, High-Risk Covid-19 Patients that Should be Ramped-Up Immediately as Key to the Pandemic Crisis, Harvey A Risch, May 27, 2020, American Journal of Epidemiology
Five studies, including two controlled clinical trials, have demonstrated significant major outpatient treatment efficacy. Hydroxychloroquine+azithromycin has been used as standard-of-care in more than 300,000 older adults with multicomorbidities, with estimated proportion diagnosed with cardiac arrhythmias attributable to the medications 47/100,000 users … These medications need to be widely available and promoted immediately for physicians to prescribe.
Continue reading Anti-HCQ Paper in The Lancet Uses Fake Data